Pharmaceutical Purchasing: a Review of the Landscape and Implications for Antidotal Therapies

[1]  A. Kesselheim,et al.  New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges. , 2022, Journal of the American Medical Association (JAMA).

[2]  Kristine A. Sobolewski,et al.  Optimization of antidote stocking, availability, and administration practices for a large multihospital organization. , 2022, American Journal of Health-System Pharmacy.

[3]  J. Graff,et al.  Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review , 2022, Journal of managed care & specialty pharmacy.

[4]  C. Pedersen,et al.  ASHP National Survey of Health-System Specialty Pharmacy Practice-2020. , 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  R. Krueger,et al.  Association of Wealth With Longevity in US Adults at Midlife , 2021, JAMA health forum.

[6]  M. Mazer-Amirshahi,et al.  How Can We “Get the Lead Out” Without Chelators? , 2021, Journal of Medical Toxicology.

[7]  Christoph U. Lehmann,et al.  Survey of Hospital Chargemaster Transparency , 2021, Applied Clinical Informatics.

[8]  B. Farmer,et al.  ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic , 2020, Journal of Medical Toxicology.

[9]  Mollye M. Demosthenidy,et al.  Association of Nonprofit Hospitals’ Charitable Activities With Unreimbursed Medicaid Care After Medicaid Expansion , 2020, JAMA Network Open.

[10]  H. Krumholz,et al.  Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017. , 2019, Circulation.

[11]  D. Himmelstein,et al.  Medical Bankruptcy: Still Common Despite the Affordable Care Act. , 2019, American journal of public health.

[12]  K. Schulman,et al.  The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians , 2018, American heart journal.

[13]  Philip M. Alberti,et al.  Changes in Teaching Hospitals’ Community Benefit Spending After Implementation of the Affordable Care Act , 2018, Academic medicine : journal of the Association of American Medical Colleges.

[14]  Phuong. Le,et al.  Combating Substandard and Counterfeit Medicines by Securing the Pharmaceutical Supply Chain: The Drug Supply Chain Security Act (DSCSA) of 2013. , 2018, Innovations in pharmacy.

[15]  Michael R Elliott,et al.  Association of a Negative Wealth Shock With All-Cause Mortality in Middle-aged and Older Adults in the United States , 2018, JAMA.

[16]  Lewis S. Nelson,et al.  ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes , 2017, Journal of Medical Toxicology.

[17]  B. Ippolito,et al.  Mystery Of The Chargemaster: Examining The Role Of Hospital List Prices In What Patients Actually Pay. , 2017, Health affairs.

[18]  K. Osterhoudt,et al.  Rising cost of antidotes in the U.S.: cost comparison from 2010 to 2015 , 2017, Clinical toxicology.

[19]  A. Kesselheim,et al.  The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. , 2016, JAMA.

[20]  Michael F. Kamali,et al.  Billing and Reimbursement for a Bedside Toxicology Service at a Tertiary Care Academic Center During Its First Fiscal Year , 2015, Journal of Medical Toxicology.

[21]  David T. Huang,et al.  Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency Care , 2018, Annals of emergency medicine.

[22]  R. Zaken,et al.  The Association between Income and Life Expectancy , 2017 .